IN8BIO, INC. Increase (Decrease) in Prepaid Expense and Other Assets
IN8BIO, INC. (INAB) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$248.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- IN8BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$181.00K.
- IN8BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$67.00K.
- IN8BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$291.00K.
- IN8BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $564.00K, a 137.97% increase year-over-year.
- IN8BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$670.00K.
- IN8BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.89M.
- IN8BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$689.00K, a 132.92% decline from fiscal 2022.
- IN8BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $2.09M, a 11.57% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$248.00K 10-Q · filed 2026-08-06 | -$539.00K derived: sum of 3 quarters · filed 2026-08-06 | $25.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$67.00K 10-Q · filed 2026-05-07 | -$358.00K derived: sum of 2 quarters · filed 2026-05-07 | $206.00K derived: sum of 3 quarters · filed 2026-05-07 | -$116.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $273.00K derived: sum of 2 quarters · filed 2026-03-12 | -$49.00K derived: sum of 3 quarters · filed 2026-08-06 | -$670.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $564.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $242.00K derived: sum of 2 quarters · filed 2026-08-06 | -$379.00K 10-Q · filed 2025-11-06 | -$1.63M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$943.00K 10-Q · filed 2026-08-06 | -$2.19M derived: sum of 3 quarters · filed 2026-08-06 | -$1.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$621.00K 10-Q · filed 2026-05-07 | -$1.87M derived: sum of 2 quarters · filed 2026-05-07 | -$1.63M derived: sum of 3 quarters · filed 2026-05-07 | -$1.91M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.01M derived: sum of 2 quarters · filed 2026-03-12 | -$1.29M derived: sum of 3 quarters · filed 2026-03-12 | -$1.89M 10-K · filed 2026-03-12 |
| 2024-09-30 | $237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$38.00K derived: sum of 2 quarters · filed 2025-11-06 | -$641.00K 10-Q · filed 2025-11-06 | -$973.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$275.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$878.00K 10-Q · filed 2025-08-07 | -$1.21M derived: sum of 3 quarters · filed 2025-08-07 | $13.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$603.00K 10-Q · filed 2025-05-07 | -$935.00K derived: sum of 2 quarters · filed 2025-05-07 | $288.00K derived: sum of 3 quarters · filed 2025-05-07 | -$782.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$332.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $891.00K derived: sum of 2 quarters · filed 2025-03-13 | -$179.00K derived: sum of 3 quarters · filed 2025-03-13 | -$689.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $153.00K derived: sum of 2 quarters · filed 2024-11-12 | -$357.00K 10-Q · filed 2024-11-12 | $1.69M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.58M 10-Q · filed 2024-08-08 | $465.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.22M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$510.00K 10-Q · filed 2024-05-09 | $1.53M derived: sum of 2 quarters · filed 2024-05-09 | $2.29M derived: sum of 3 quarters · filed 2024-05-09 | $2.38M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $2.79M derived: sum of 2 quarters · filed 2024-03-14 | $2.88M derived: sum of 3 quarters · filed 2024-03-14 | $2.09M 10-K · filed 2024-03-14 |
| 2022-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $840.00K derived: sum of 2 quarters · filed 2023-11-09 | $48.00K 10-Q · filed 2023-11-09 | -$1.19M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$702.00K 10-Q · filed 2023-08-10 | -$1.94M derived: sum of 3 quarters · filed 2023-08-10 | $1.11M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$792.00K 10-Q · filed 2023-05-12 | -$2.03M derived: sum of 2 quarters · filed 2023-05-12 | $1.02M derived: sum of 3 quarters · filed 2023-05-12 | $922.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.81M derived: sum of 2 quarters · filed 2023-03-30 | $1.71M derived: sum of 3 quarters · filed 2023-03-30 | $1.88M 10-K · filed 2023-03-30 |
| 2021-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.96M derived: sum of 2 quarters · filed 2022-11-10 | $3.12M 10-Q · filed 2022-11-10 | $3.12M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $62.00K 10-Q · filed 2022-08-12 | $65.00K derived: sum of 3 quarters · filed 2022-08-12 | $67.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $162.00K 10-Q · filed 2022-05-12 | $165.00K derived: sum of 2 quarters · filed 2022-05-12 | $167.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $5.00K derived: sum of 2 quarters · filed 2022-03-17 | -$3.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$6.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$8.00K 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |